Geneve, Switzerland
Intelligent Sensory Concept (ISC), operating under the brand name Biolux Medical, is an innovative biotechnology company, founded in 2007. Based in Switzerland, the company is at the forefront of medical device innovation with specialization in photomodulation.
As part of a Franco-Swiss consortium, Biolux Medical leverages cutting-edge research to develop medical devices that utilize advanced photomodulation techniques. Their mission is to enhance patients' lives by providing revolutionary therapeutic solutions. Notably, the company is collaborating exclusively with the Institut de Neurosciences de Montpellier (INM), INSERM, focusing on non-invasive pain treatment research which holds significant promise for professional and ambulatory settings.
In its growth trajectory, Biolux Medical secured a $2.00M Series A investment on May 18, 2018, led by Rhône Finance. This funding underscores its potential and supports its ambitious e-health interface development aimed at personalizing patient care.
